Tag: Human Papillomavirus (HPV)
Vaccine Program Recovery Difficult After Public Scares
Misinformation is threat to resilience of vaccination programs globally, authors say
Mortality Risk in Oropharynx Cancer Varies Based on HPV Status
Patients with OPC with HPV-negative tumors have increased risk for head and neck cancer mortality
CDC: Young Adults Who Ever Received HPV Vaccine on the Rise
2013 to 2018 saw increase in percentage having received one or more doses, recommended number of doses
Routine HPV Testing May Be Warranted for Sinonasal Cancers
HPV-positive sinonasal squamous cell carcinoma associated with improved overall survival
Protection Similar With Single, Multiple HPV Vaccine Doses
Infection with HPV 6, 11, 16, 18 less prevalent among women receiving one, two, three doses of HPV vaccine
Extending HPV Vaccination to Age 45 Provides Small Additional Benefit
Vaccinating women and men to age 45 years predicted to have high costs per QALY gained
Studies Confirm Safety of 9-Valent HPV Vaccination
Studies based on searching Vaccine Adverse Event Reporting System, six Vaccine Safety Datalink sites
Mailing HPV Kits to Underscreened Women Can Up Screening
No significant difference found in detection of CIN2+ or treatment with intervention versus usual care
HPV DNA Identified in Oral Cavity of 6.2 Percent of Teen Girls
Oral HPV detection decreased with number of years since first engaging in sexual activities
Incidence of HPV-Positive Head and Neck Cancer Up in the U.S.
From 2013 to 2014, incidence of HPV-positive oropharyngeal cancers was 4.62 per 100,000 persons
